Rendering of SHINE medical isotope facility in Wisconsin.

Medical Isotope Production Facility

Sargent & Lundy performed structural and architectural design for a first-of-a-kind medical isotope production facility.

Client

SHINE Medical Technologies

Location

Janesville, Wisconsin

Milestones

  • NRC construction permit application: Submitted June 2013; permit issued February 2016
  • Site groundbreaking ceremony: May 2019
  • Successful nuclear process prototype testing: June 2019
  • NRC operating license application: Submitted July 2019
  • Completion of weather-tight building construction: March 2021

Shiven Sulkar

Senior Vice President & Director of Nuclear Power

312-269-6473

Email

Project Details

Client

SHINE Medical Technologies

Location

Janesville, Wisconsin

Milestones

  • NRC construction permit application: Submitted June 2013; permit issued February 2016
  • Site groundbreaking ceremony: May 2019
  • Successful nuclear process prototype testing: June 2019
  • NRC operating license application: Submitted July 2019
  • Completion of weather-tight building construction: March 2021

Shiven Sulkar

Senior Vice President & Director of Nuclear Power

312-269-6473

Email

Medical Isotope Production Facility


Project Highlights

  • Nuclear Regulatory Commission compliant, safety-related production facility.
  • 55,000-square-foot structure designed for safe-shutdown earthquake, tornado, and aircraft impact.
  • First-of-a-kind facility will use diluted uranium formerly used in nuclear weapons to produce life-saving medical isotopes.

Project Description

Sargent & Lundy worked with SHINE on the design and licensure of a new medical isotope production facility. This first-of-a-kind facility utilizes neutron accelerators to turn low-enriched uranium, created by diluting former nuclear weapons, into medical isotopes such as molybdenum-99. Moly-99 is the essential component in medical imaging procedures used to diagnose conditions such as heart disease, bone disease and cancer.

Project Scope

Starting in 2011, SHINE contracted Sargent & Lundy to perform a variety of services, including:

  • NRC licensing support.
  • Nuclear and environmental calculations.
  • Conceptual balance-of-plant system layout and design.
  • Detailed structural and architectural design.

Early support from Sargent & Lundy helped SHINE establish its facility layout, further its nuclear process design, and secure financial investments necessary to fund construction.

In 2018, SHINE partnered with Sargent & Lundy to perform the detailed structural and architectural design of the safety-related production facility and associated administrative building. Detailed design of the main structural and architectural systems was substantially completed in early 2019. By meeting this deadline, Sargent & Lundy supported SHINE’s Final Safety Analysis Report submittal to the NRC in July 2019, followed by the start of safety-related construction in November 2019.

Sargent & Lundy supported SHINE with:

  • NRC licensing activities.
  • Detailed design of ancillary structural systems and components.
  • Construction support activities (both on-site and remote).
  • Drawing development for an extensive system of embedded conduits.
  • Design of pipe, electrical raceway, and HVAC supports.

Read more about our nuclear power services.